$NNOXAug 10, 2026, 8:10 AM ETAI processed
Nanox.AI optimizes on‐premise CT imaging AI for Intel Core Ultra processors
AI Summary
Nanox.AI said it optimized its medical imaging AI application framework to run on Intel Core Ultra processors using Intel’s OpenVINO and demonstrated successful, efficient on‐device inference. This enables on‐premise CT AI inference that keeps imaging data inside hospital infrastructure and may ease evaluation and deployment into existing CT workflows, but the company disclosed no commercial deployments, timelines, or quantitative performance metrics.
Positives
- Demonstrated successful, efficient inference of Nanox.AI framework on Intel Core Ultra hardware with OpenVINO
- Enables on‑premise/edge inference that can keep imaging data local and reduce dependence on cloud connectivity
- Designed to integrate with existing CT workflows to extract additional clinical insights from routine scans
Negatives
- No commercial deployment, customer pilots, or revenue impact announced
- No quantitative performance, throughput, latency, or validation metrics provided
- Press release is a technical optimization update rather than a clinical or regulatory milestone